EP3341037B1 - Composition adhésive - Google Patents

Composition adhésive Download PDF

Info

Publication number
EP3341037B1
EP3341037B1 EP16762725.6A EP16762725A EP3341037B1 EP 3341037 B1 EP3341037 B1 EP 3341037B1 EP 16762725 A EP16762725 A EP 16762725A EP 3341037 B1 EP3341037 B1 EP 3341037B1
Authority
EP
European Patent Office
Prior art keywords
composition
adhesive
skin
absorption
seal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP16762725.6A
Other languages
German (de)
English (en)
Other versions
EP3341037A1 (fr
Inventor
Dorrit Diana Israelson
Henrik Olsen
Charlotte Klein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coloplast AS
Original Assignee
Coloplast AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coloplast AS filed Critical Coloplast AS
Priority to EP19205687.7A priority Critical patent/EP3636290B1/fr
Publication of EP3341037A1 publication Critical patent/EP3341037A1/fr
Application granted granted Critical
Publication of EP3341037B1 publication Critical patent/EP3341037B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/04—Metals or alloys
    • A61L27/06—Titanium or titanium alloys
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/18—Homopolymers or copolymers of hydrocarbons having four or more carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04—Homopolymers or copolymers of esters
    • C08L33/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical
    • C08L33/08—Homopolymers or copolymers of acrylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L53/00—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
    • C08L53/02—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers of vinyl-aromatic monomers and conjugated dienes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/14—Adhesives for ostomy devices
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/04—Homopolymers or copolymers of ethene
    • C08L23/08—Copolymers of ethene
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/10—Homopolymers or copolymers of propene
    • C08L23/14—Copolymers of propene
    • C08L23/147—Copolymers of propene with monomers containing other atoms than carbon or hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/18—Homopolymers or copolymers of hydrocarbons having four or more carbon atoms
    • C08L23/20—Homopolymers or copolymers of hydrocarbons having four or more carbon atoms having four to nine carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/02—Homopolymers or copolymers of acids; Metal or ammonium salts thereof

Definitions

  • the invention relates to an adhesive composition for attachment to skin.
  • an adhesive composition for attachment to skin comprising 10-14% (w/w) polyethylene copolymer, 15-20% (w/w) polypropylene glycol (PPG), 13-18% (w/w) polyolefin, 10-15% (w/w) polybutene, 1-5% (w/w) wax, 4-8% (w/w) polyacrylic acid (PAA), and a total of 30-35% (w/w) of one or more further absorbent material.
  • the polyethylene copolymer is selected from the group consisting of poly(ethylene vinyl acetate) (PEVA), poly(ethylene vinyl acetate carbon monoxide), poly(ethylene butyl acetate), poly(ethylene vinyl alcohol), poly(ethylene butyl acrylate), and poly(ethylene butyl acrylate carbon monoxide).
  • PEVA poly(ethylene vinyl acetate)
  • poly(ethylene vinyl acetate carbon monoxide) poly(ethylene butyl acetate)
  • poly(ethylene vinyl alcohol) poly(ethylene butyl acrylate)
  • poly(ethylene butyl acrylate carbon monoxide) poly(ethylene butyl acrylate carbon monoxide).
  • the polyethylene copolymer is PEVA.
  • the adhesive polymer component is a styrene-ethylene/butylene-styrene (SEBS) block copolymer.
  • SEBS styrene-ethylene/butylene-styrene
  • the composition comprises 10-13% (w/w), such as 10-12% (w/w) of the polyethylene copolymer. In embodiments, the composition does not comprise polyethylene copolymer.
  • the polyethylene copolymer is a polar polyethylene copolymer.
  • the polyethylene copolymer is poly(ethylene vinyl acetate) (PEVA).
  • the PEVA has a vinyl acetate content of at least 40% (w/w), such as at least 50% (w/w), such as at least 60% (w/w), such as at least 70% (w/w).
  • the PEVA has a vinyl acetate content of 40-80% (w/w), such as 50-80% (w/w), such as 60-80% (w/w).
  • the PEVA has a vinyl acetate content of 70% (w/w).
  • the PEVA is LEVAMELT 700 from Lanxess.
  • the composition comprises 16-19% (w/w), such as 16-18% (w/w) PPG. In embodiments, the composition does not comprise PPG.
  • the PPG has an average molecular weight of 1.000-3.000 g/mol. In embodiments, the PPG has an average molecular weight of 2.000 g/mol. In embodiments, the PPG is Voranol 2000 L from Dow Chemical Company.
  • the composition comprises 14-18% (w/w) polyolefin, such as 15-17% (w/w) polyolefin.
  • the polyolefin is a copolymer of propylene and ethylene.
  • the polyolefin is Eastoflex E1016PL-1 Amorphous Polyolefin from Eastman Chemical Company.
  • the composition comprises 10-15% (w/w) polybutene, such as 12-14% (w/w) polybutene.
  • the polybutene has a number average molecular weight of 4,000-8,000, such as 5,000-7,000, such as 6,000.
  • the polybutene is Indopol Polybutene Grade H-18000 from INEOS.
  • the composition comprises 4-8% (w/w), such as 5-7% (w/w) PAA.
  • the PAA is crosslinked PAA. In embodiments, the PAA is partially neutralized PAA. In embodiments, the PAA is Carbopol 974P NF Polymer from Lubrizol Advanced Material, Inc. In embodiments, the PAA has a carboxylic acid content in the range 56-68%. In embodiments, the PAA has a viscosity of 20,000-50,000 cP, such as 25,000-45,000 cP, such as 25,000-40,000 cP, such as 29,400-39,400 cP at 25 degrees Celsius when measured with a Brookfield RVT at 20 RPM and neutralized to pH 7.3-7.8 using 0.5 wt% mucilage and spindle no. 6.
  • the composition comprises a total of 30-35% (w/w) of one or more further absorbent material(s).
  • the one or more further absorbent material(s) is selected from the group consisting of hydrocolloid, starch, water soluble salt, mono, di- and oligosaccharides, sugar alcohols, polypeptides, organic acids, inorganic acids, amino acids, amines, urea, super absorbent particles such as polyacrylic acid, glycols such as polyethylene glycol, fumed silica, and bentone.
  • the at least one further absorbent material is selected from the group consisting of hydrocolloid, starch, water soluble salt, mono, di- and oligosaccharides, sugar alcohols, polypeptides, organic acids, inorganic acids, amino acids, amines, urea, super absorbent particles such as polyacrylic acid, glycols such as polyethylene glycol, fumed silica, and bentone.
  • the hydrocolloid is selected from guar gum, locust bean gum, pectin, potato starch, alginates, gelatine, xantan or gum karaya, cellulose derivatives, salts of carboxymethyl cellulose, sodium carboxymethyl cellulose, methyl cellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, sodium starch glycolate, and polyvinylalcohol.
  • the water soluble salt is selected from NaCl, CaCl 2 , K 2 SO 4 , NaHCO 3 , Na 2 CO 3 , KCl, NaBr, Nal, KI, NH 4 Cl, AlCl 3 , CH 3 COONa, CH 3 COOK, HCOONa, and HCOOK.
  • the at least one further absorbent material is hydroxyethylcellulose with a weight average molecular weight in the range 500,000-2,000,000 g/mol, such as 750,000-1,500,000 g/mol, such as 800,000-1,200,000 g/mol, such as 1,000,000 g/mol.
  • the at least one further absorbent material is Natrosol 250HX hydroethylcellulose from Ashland.
  • the composition further comprises a wax.
  • the composition comprises 1-5% (w/w), such as 2-4% (w/w) wax.
  • the wax is a microcrystalline wax. In embodiments, the wax is a polyethylene wax. In embodiments, the wax is Sasolwax 7837 from Sasol Wax GmbH.
  • the composition consists of 10-14% (w/w) polyethylene copolymer, 15-20% (w/w) PPG, 13-18% (w/w) polyolefin, 10-15% (w/w) polybutene, 1-5% (w/w) wax, 4-8% (w/w) PAA, and a total of 29-35% (w/w) of one or more further absorbent material(s).
  • the composition has an absorption at 2 hours, measured as described herein, of at least 0.1 g/cm 2 /2h, such as at least 0.15 g/cm 2 /2h, such as 0.15-3.0 g/cm 2 /2h.
  • An absorption of at least 0.1 g/cm 2 /2h is deemed acceptable for ensuring that the composition can absorb sufficient liquid to properly transport moisture away from the skin surface and keep the skin dry.
  • a higher absorption, such as at least 0.15 g/cm 2 /2h, is preferable, provided that such higher absorption does not lead to an insufficient gel strength.
  • the composition has an absorption at 24 hours, measured as described herein, of at least 0.5 g/cm 2 /24h, such as at least 0.6 g/cm 2 /24h, such as 0.6-1.1 g/cm 2 /24h.
  • An absorption of at least 0.5 g/cm 2 /24h is deemed acceptable for ensuring that the composition can absorb sufficient liquid to properly transport moisture away from the skin surface and keep the skin dry.
  • a higher absorption, such as at least 0.6 g/cm 2 /24h, is preferable, provided that such higher absorption does not lead to an insufficient gel strength.
  • the composition has a gel strength, measured as described herein, below 3 N, such as below 2 N, such as below 1 N.
  • the composition has a gel strength, measured as described herein, in the range 0.75-1.5 N or 1-2 N.
  • a gel strength of below 3 N is deemed acceptable for ensuring that residue is very rarely left on the skin when removing an adhesive composition that has absorbed liquid.
  • the gel strength is below 2 N, which ensures that practically no residue is left on the skin when the adhesive composition has absorbed liquid and is subsequently removed from the skin.
  • the composition has an absorption at 2 hours, measured as described herein, of 0.15-0.30 g/cm 2 /2h and an absorption at 24 hours, measured as described herein, of 0.6-1.1 g/cm 2 /24h, and a gel strength, measured as described herein, in the range 0.75-1.5 N.
  • a composition with absorption and gel strength in these ranges exhibit a good balance between absorbent and cohesive properties.
  • an adhesive composition for attachment to the skin comprising an adhesive polymer and one or more absorbent materials, wherein the composition has an absorption at 2 hours, measured as described herein, of 0.15-0.30 g/cm 2 /2h and an absorption at 24 hours, measured as described herein, of 0.6-1.1 g/cm 2 /24h, and a gel strength, measured as described herein, in the range 0.75-1.5 N.
  • the composition has a G* at 1 Hz, measured as described herein, in the range 45,000-1,500,000 Pa. In embodiments, the G*, measured as described herein, at 40 Hz is in the range 200,000-3,000,000 Pa. In embodiments, the G*, measured as described herein, at 10 Hz is in the range 100,000-2,500,000 Pa. In embodiments, the G*, measured as described herein, at 0.1 Hz is in the range 15,000-1,000,000 Pa. In embodiments, the G*, measured as described herein, at 0.003 Hz is in the range 3,000-400,000 Pa. In embodiments, the composition has G* values within the above recited ranges for all mentioned frequencies. In preferred embodiments, the composition has a G* at 1 Hz, measured as described herein, in the range 75,000-1,000,000 Pa, such as 75,000-500,000 Pa, such as 75,000-300,000 Pa.
  • the composition has a tan(delta) at 1 Hz, measured as described herein, in the range 0.5-3. In embodiments, the composition has a tan(delta) at 40 Hz, measured as described herein, in the range 0.5-2. In embodiments, the composition has a tan(delta) at 10 Hz, measured as described herein, in the range 0.5-3. In embodiments, the composition has a tan(delta) at 0.1 Hz, measured as described herein, in the range 0.5-3. In embodiments, the composition has a tan(delta) at 0.003 Hz, measured as described herein, in the range 0.35-2.5.
  • the composition has tan(delta) values within the above recited ranges for all mentioned frequencies.
  • the composition has a tan(delta) at 1 Hz, measured as described herein, in the range 0.6-1.5, such as 0.7-1.0 or 1.0-1.5.
  • G* and tan(delta) values in the above ranges for various frequencies ensure that the composition has a good balance between elastic and plastic properties.
  • the composition is mouldable.
  • mouldable is defined as being capable of significant non-elastic deformation when a user applies pressure to the composition.
  • the composition is capable of at least 10%, such as at least 20%, such as at least 30% non-elastic deformation.
  • non-elastic deformation is meant that the composition essentially retains its shape after deformation with elastically reverting to its original shape.
  • the composition retains at least 70%, such as at least 80%, such as at least 90% of its adhesion at 10% deformation.
  • the composition retains at least 70%, such as at least 80%, such as at least 90% of its adhesion at 20% deformation.
  • the composition retains at least 70%, such as at least 80%, such as at least 90% of its adhesion at 30% deformation.
  • adhesion is measured as peel force.
  • an adhesive device for attachment to a skin surface of a user, the device comprising an adhesive composition as described herein and at least one release liner.
  • the device has a skin-facing surface and a surface facing away from the skin during use, and the release liner is disposed on the skin-facing surface.
  • a second release liner is disposed on the surface facing away from the skin during use.
  • the adhesive device is ring or oval shaped with a through-going hole for fitting around a stoma of the user.
  • the outer diameter of the device is in the range 30-60 mm, such as 40-50 mm. If the device is not circular, the outer diameter is to be understood as the maximum diameter, meaning the maximum length from edge to edge of a line through the centre of the device.
  • the diameter of the hole is in the range 10-25 mm, such as 15-20 mm. If the hole is not circular, the outer diameter is to be understood as the maximum diameter, meaning the maximum length from edge to edge of a line through the centre of the hole.
  • the device may be made in versions with different sized holes in order to fit around different sized stomas.
  • the thickness of the device including release liner(s) is in the range 3.5-5.5 mm, such as 4-5 mm. In embodiments, the thickness of the device, excluding release liners, is in the range 2-3 mm.
  • the device is an adhesive barrier ring for fitting around a stoma.
  • the use comprises a further step of attaching the device to an adhesive baseplate of an ostomy device.
  • the adhesive device is attached to the baseplate before the adhesive device is attached to the skin. In such a situation, the adhesive device is first adhered to the baseplate and the baseplate with the adhesive device is then attached to the skin surrounding the stoma. In embodiments, the adhesive device is attached to the skin and the baseplate is subsequently attached to the adhesive device and/or the skin surrounding the stoma.
  • the adhesive composition for attachment to skin.
  • the adhesive composition is for attachment around the stoma of an ostomy device user.
  • the adhesive composition may be used to provide a seal around the stoma and can be used in combination with a regular ostomy device comprising a collecting pouch and an adhesive wafer.
  • the user will sometimes start by fitting the adhesive composition closely around the stoma and will then apply the adhesive wafer of the ostomy device on top of or immediately next to the adhesive composition.
  • the user may start by applying the adhesive composition to the adhesive wafer of the ostomy device before attaching the combined device to the skin surrounding the stoma. In either way, a tight and secure seal can be provided around the stoma, thereby protecting against leakage.
  • the adhesive composition is absorbent, meaning that it is capable of absorbing liquid from the surroundings. This will allow the composition to absorb moisture from the skin around the stoma, which will help keep the skin surface dry, thereby preventing damage to the skin.
  • the adhesive composition is preferably mouldable, meaning that it can be shaped by the user applying pressure to the composition.
  • the composition can be shaped to closely match the shape of a given stoma and thereby provide a tight seal around the stoma.
  • any release liners are first removed and the adhesive compositions, typically in the form of a ring, is placed on the skin surrounding the stoma.
  • the adhesive composition may then be moulded by pressing it in order to make it fit closely around the stoma.
  • a regular ostomy device including an adhesive wafer and a collecting bag, may be attached to the skin and/or the outer surface of the adhesive device around the stoma.
  • composition is removed from the skin, optionally together with the ostomy device, and discarded.
  • the composition can absorb moisture from the skin and that it can be easily removed in one piece.
  • the adhesive composition will swell and become less cohesive.
  • absorption of liquid will to some degree compromise the cohesiveness or structural integrity of the adhesive composition and will increase the risk that the adhesive breaks apart when removed from the skin.
  • Such breaking apart during removal is referred to as cohesive failure and will result in adhesive residue being left on the skin of the user. This is problematic because such residue will be difficult to remove and will make it hard to attach a new adhesive to the skin.
  • the present inventors have identified adhesive compositions that strike a good balance between absorption and cohesion. Particularly, the inventors have found that adhesive compositions with ingredients within the claimed ranges will ensure both sufficient absorption and cohesion.
  • the new composition provides an additional high gel-strength, which makes the seal coherent and durable.
  • the new composition will not dissolve and erode as easily because the increased gel-strength prevents it from breaking up into little pieces.
  • this means that the new adhesive composition should leave less residue and come off in one piece along with the baseplate.
  • a high durability should increase the possibility of extended wear-time if needed.
  • the DMA was carried out as follows by a frequency sweep at 32°C and 1% CD (controlled deformation). Samples were prepared by thermoforming to a 1 mm thick adhesive film between two release liners. With a punching tool, a round sample of 25 mm in diameter was cut out. The release liners were removed and the samples placed in an Anton Paar Physica MCR 301 rheometer. The geometry applied was parallel plates 25 mm and the force applied was 5 N. After applying 5 N force, 15 minutes of thermal equilibration of the samples at 32 °C were carried out before the measurements.
  • Samples were prepared by thermoforming to a 1 mm thick adhesive film between two release liners. With a punching tool, samples were punched out. Sample size was 25 x 25 mm. The release liners were removed. The samples were glued to an object glass and placed in a beaker with physiological salt water and placed in an incubator at 37 °C.
  • the sample was weighed at the outset (M(start)) and after 2 hours (M(2 hours) and/or 24 hours (M(2 hours)). Before weighing, the object glass was dried off with a cloth. For a 25x25 mm sample the area was 6.25 cm 2 (the surface edges were left out of the area).
  • the cohesiveness or structural integrity of the adhesive composition following significant absorption is evaluated by testing the gel strength of the adhesive composition.
  • a 1 mm thick sample of the adhesive composition is immersed in isotonic saline for 24 hours and the strength of the resulting swelled adhesive is tested by pressing a probe into the gel and measuring the distance travelled as a function of the force.
  • a low number means that the probe is only able to be pushed a short distance into the sample at a given force, thus signifying a high gel strength, corresponding to a high cohesion and structural integrity.
  • the components were mixed on a Herman Linden Z blade mixer at a chamber temperature of 95°C and a mixing speed of 20 rpm.
  • the polymer components were added first and mixed.
  • the absorbent components were added to the mixture and further mixed.
  • compositions number 56 and 86 Measurements were carried out on four exemplary adhesive compositions falling within the scope of the invention.
  • the Eakin barrier ring is a polyolefin-based adhesive comprising hydrocolloids, most likely a type of cellulose and guar gum.
  • the Eakin barrier ring does not comprise poly(acrylic acid).
  • the Adapt barrier ring also does not comprise poly(acrylic acid).
  • composition of the tested adhesives is indicated in the table below.
  • the amount of the different components are all given as % (w/w).
  • Absorption after 2 hours is given as "Abs, 2h”, is measured as described herein and has the unit g/cm 2 /2h.
  • Absorption after 24 hours is indicated as “Abs, 24h”, is measured as described herein, and has the unit g/cm 2 /24h.
  • Gel strength is measured as described herein and has the unit Newton (N).
  • composition number/product 56 86 61 94 Eakin Adapt EVA 11.2 12.52 PPG 16.8 18.78 SEBS 6.2 6.618 Polyolefin 13.7 16.5 3.1 3.3 Polybutene 11.6 14 37.2 39.78 Wax 2.6 3.1 3.1 PAA 5 6 20 15 Cellulose 20 18 20 15 Guar gum 5 5 CMC 4 5.3 10.3 Gelatine 7.1 Alginate 19.1 Potato starch 5 Abs, 2h 0.19 0.20 0.22 0.29 0.40 0.46 Abs, 24h 0.67 0.62 0.81 1.04 0.84 1.13 Gel strength 1.1 1.2 0.9 0.9 4.6 5.1
  • All of the tested compositions including the two comparative examples with the commercial Eakin and Adapt products, display sufficient water absorption at 2h and 24h to be usable on skin.
  • the Eakin and Adapt products display somewhat higher absorption after 2h than the tested inventive compositions. After 24h, the absorption has levelled out, with the compositions 56 and 86 showing a tendency to be slightly lower than the rest, although still well within the range usable for skin adhesives.
  • inventive compositions display significantly higher gel strength (lower numbers in the gel strength test as described herein) when compared to the commercial adhesive products. This means that the inventive compositions are much more cohesive after absorption and retain their structural integrity, even after having absorbed large amounts of liquid. In use, this means that the inventive compositions can easily be removed from the skin in one piece after use, without leaving significant residue on the skin of the user.
  • the inventive compositions all display a good balance between sufficient absorption and excellent gel strength. This means that the compositions are capable of absorbing moisture and keep the skin sufficiently dry during use, while at the same time maintaining their cohesion and structural integrity enough so that the adhesive composition does not fall apart during removal leaving residue on the skin.
  • the beneficial effects are obtained with both a PEVA-PPG mixture and with a SEBS copolymer as the adhesive polymer component.
  • the clinical study product was designed to have properties in the relevant intervals, namely a gel strength of 0.9-1.2, an absorption at 2h of 0.19-0.29 g/cm 2 /2h, and an absorption at 24h of 0.67-1.04 g/cm 2 /24h.
  • the composition was provided as a mouldable sealing ring (referred to herein as the "Brava® Protective Seal” or "new seal”).
  • the product was presented to ostomy users and the individual users were asked to compare the new composition to their currently used product. A total of 135 users were included with 34% normally using the Eakin Cohesive, 31% using the Brava Mouldable Ring, 18% using the Adapt product, and 17% using other commercial products.
  • users preferred the new Brava® Protective Seal over their usual seal.
  • the new seal was preferred, particularly, because it left fewer residues on fingers and on stomach. Further, it was evaluated to be very durable, and more so compared to usual seal. In relation to easiness of appliance change, users also evaluated the seal to be easy to handle, apply, and remove, and easy to clean away from the peristomal skin.
  • the clinical study thus confirmed the hypothesized link between striking a balance between gel strength and absorption and achieving beneficial properties, durability in particular, in an actual use situation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Claims (14)

  1. Composition adhésive destinée à une fixation à la peau, la composition comprenant 10-14% (p/p) d'un copolymère de polyéthylène, 15-20% (p/p) de polypropylène glycol (PPG), 13-18% (p/p) de polyoléfine, 10-15% (p/p) de polybutène, 1-5% (p/p) de cire, 4-8% (p/p) d'acide polyacrylique (PAA), et un total de 30-35% (p/p) d'un ou plusieurs autres matériaux absorbants.
  2. Composition selon la revendication 1, où la composition est constituée de 10-14% (p/p) d'un copolymère de polyéthylène, 15-20% (p/p) de PPG, 13-18% (p/p) de polyoléfine, 10-15% (p/p) de polybutène, 1-5% (p/p) de cire, 4-8% (p/p) de PAA, et d'un total de 30-35% (p/p) d'un ou plusieurs autres matériaux absorbants.
  3. Composition selon l'une quelconque des revendications précédentes, où la composition possède une absorption à 2 heures, mesurée tel que décrit ici, d'au moins 0,1 g/cm2/2 h.
  4. Composition selon l'une quelconque des revendications précédentes, où la composition possède une absorption à 24 heures, mesurée tel que décrit ici, d'au moins 0,5 g/cm2/24 h.
  5. Composition selon l'une quelconque des revendications précédentes, où la composition possède une résistance du gel, mesurée tel que décrit ici, inférieure à 4 N.
  6. Dispositif adhésif destiné à une fixation à la surface cutanée d'un utilisateur, le dispositif comprenant une composition adhésive selon l'une quelconque des revendications précédentes, et au moins une bande antiadhésive.
  7. Dispositif selon la revendication 6, où le dispositif possède une surface du côté de la peau et une surface à l'opposé de la peau lors de l'utilisation, et où la bande antiadhésive est disposée sur la surface du côté de la peau.
  8. Dispositif selon l'une quelconque des revendications 6-7, où une deuxième bande antiadhésive est disposée sur la surface à l'opposé de la peau lors de l'utilisation.
  9. Dispositif selon l'une quelconque des revendications 6-8, où le dispositif adhésif est en forme de cercle ou d'ovale avec un orifice traversant destiné à s'ajuster autour d'une stomie de l'utilisateur.
  10. Dispositif selon l'une quelconque des revendications 6-9, où le diamètre externe du dispositif se trouve dans la plage de 30-60 mm.
  11. Dispositif selon l'une quelconque des revendications 6-10, où le diamètre de l'orifice se trouve dans la plage de 10-25 mm.
  12. Dispositif selon l'une quelconque des revendications 6-11, où l'épaisseur du dispositif, y compris la ou les bandes antiadhésives, se trouve dans la plage de 3,5-5,5 mm.
  13. Utilisation du dispositif adhésif selon l'une quelconque des revendications 6-12, comprenant les étapes consistant à
    - fournir un dispositif selon l'une quelconque des revendications 6-12,
    - retirer une ou plusieurs bandes antiadhésives du dispositif,
    - fixer le dispositif à une surface cutanée entourant une stomie.
  14. Utilisation selon la revendication 13, comprenant une étape supplémentaire de fixation du dispositif à une plaque d'assise adhésive d'un dispositif de stomie.
EP16762725.6A 2015-08-24 2016-08-24 Composition adhésive Active EP3341037B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP19205687.7A EP3636290B1 (fr) 2015-08-24 2016-08-24 Composition adhésive

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201570544 2015-08-24
PCT/DK2016/050284 WO2017032381A1 (fr) 2015-08-24 2016-08-24 Composition adhésive

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP19205687.7A Division EP3636290B1 (fr) 2015-08-24 2016-08-24 Composition adhésive

Publications (2)

Publication Number Publication Date
EP3341037A1 EP3341037A1 (fr) 2018-07-04
EP3341037B1 true EP3341037B1 (fr) 2019-10-30

Family

ID=54065634

Family Applications (2)

Application Number Title Priority Date Filing Date
EP19205687.7A Active EP3636290B1 (fr) 2015-08-24 2016-08-24 Composition adhésive
EP16762725.6A Active EP3341037B1 (fr) 2015-08-24 2016-08-24 Composition adhésive

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP19205687.7A Active EP3636290B1 (fr) 2015-08-24 2016-08-24 Composition adhésive

Country Status (6)

Country Link
US (2) US10744224B2 (fr)
EP (2) EP3636290B1 (fr)
CN (1) CN107921175B (fr)
BR (1) BR112018003328B1 (fr)
RU (1) RU2723557C2 (fr)
WO (1) WO2017032381A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009013331A (es) 2007-06-12 2010-01-25 Convatec Technologies Inc Aparato de ostomia.
RU2519961C2 (ru) 2008-11-19 2014-06-20 Конватек Текнолоджиз Инк. Стомное приспособление с мешком
CA2766120C (fr) 2009-07-07 2018-08-14 Convatec Technologies Inc. Copolymeres de silicone amphiphiles pour applications autoadhesives
US8845606B2 (en) 2009-09-11 2014-09-30 Convatec Technologies Inc. Controlled discharge ostomy appliance and shield therefor
US10285847B2 (en) 2011-09-29 2019-05-14 Convatec Technologies Inc. Ostomy pouch with filtering system
GB201115160D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Discharge solidifier and malodour control
MX2016013987A (es) 2014-04-24 2017-01-11 Convatec Technologies Inc Sistema de filtro de bolsa de ostomia.
CA3002013C (fr) 2015-10-14 2024-02-27 Convatec Technologies Inc. Un appareil medical dote d'un systeme d'ouverture
CN111278392B (zh) * 2017-11-08 2023-08-08 科洛普拉斯特公司 具有中和剂基质的粘性薄片
RU2020117765A (ru) 2017-11-08 2021-12-08 Колопласт А/С Клейкая пластина с матрицей с нейтрализатором
MX2020004744A (es) 2017-11-09 2020-08-13 11 Health And Tech Limited Sistema y metodo de monitoreo de ostomia.
USD893514S1 (en) 2018-11-08 2020-08-18 11 Health And Technologies Limited Display screen or portion thereof with graphical user interface
EP3692956A1 (fr) 2019-02-07 2020-08-12 ConvaTec Technologies Inc. Dispositif stomique réglable convexe
US20220168131A1 (en) * 2019-04-01 2022-06-02 Coloplast A/S A barrier ring
JP7458416B2 (ja) 2019-04-25 2024-03-29 コンバテック・テクノロジーズ・インコーポレイテッド 接着剤を組み込んだオストミーウェハ、オストミーウェハを含むオストミー装置、及びオストミーウェハとオストミー装置の接触方法
CA3137966A1 (fr) 2019-04-25 2020-10-29 Convatec Technologies Inc. Plaquettes de stomie a chambre perforee, dispositifs les comprenant, et procedes d'utilisation
US11638658B2 (en) 2019-04-25 2023-05-02 Convatec Technologies, Inc. Ostomy wafers incorporating adhesives and foam layers, ostomy devices including the same, and methods of applying ostomy wafers and ostomy devices

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4204540A (en) * 1977-06-08 1980-05-27 E. R. Squibb & Sons, Inc. Ostomy composition
AU721675B2 (en) * 1996-10-22 2000-07-13 Coloplast A/S An ostomy appliance
ATE232747T1 (de) * 1996-10-22 2003-03-15 Coloplast As Eine paste
US6534572B1 (en) 1998-05-07 2003-03-18 H. B. Fuller Licensing & Financing, Inc. Compositions comprising a thermoplastic component and superabsorbent polymer
US6497949B1 (en) 2000-08-11 2002-12-24 3M Innovative Properties Company Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives
US20040241246A1 (en) 2003-05-20 2004-12-02 Lipman Roger D. A. Fluid absorbing adhesive paste
WO2004103432A2 (fr) 2003-05-20 2004-12-02 Avery Dennison Corporation Masques faciaux pour traiter des plaies cutanees
EP1791575B1 (fr) 2004-08-05 2014-10-08 Corium International, Inc. Composition d'adhesif
US20060069370A1 (en) 2004-09-30 2006-03-30 Kimberly-Clark Worldwide, Inc. Absorbent article having a liner with areas that prevent lotion and adhesive migration
WO2007044569A2 (fr) 2005-10-06 2007-04-19 H.B. Fuller Licensing & Financing, Inc. Composition indiquant l’humidité
US7943812B2 (en) 2005-12-30 2011-05-17 Colopast A/S Layered adhesive construct having a mouldable layer as skin contact surface
WO2007092290A2 (fr) 2006-02-02 2007-08-16 H.B. Fuller Licensing & Financing, Inc. Articles conducteurs contenant une composition polymère superabsorbante thermofusible et leur méthode de fabrication et leur méthode d'utilisation
WO2007092350A1 (fr) 2006-02-02 2007-08-16 H.B. Fuller Licensing & Financing, Inc. Articles pour le soin de plaies, systèmes d'administration de médicament et leurs méthodes d'utilisation
WO2007092289A2 (fr) 2006-02-02 2007-08-16 H.B. Fuller Licensing & Financing, Inc. Article de stomie à composition polymère superabsorbante thermofusible et sa méthode d'utilisation
WO2007092340A2 (fr) 2006-02-02 2007-08-16 H.B. Fuller Licensing & Financing, Inc. Articles mortuaires contenant une composition polymère superabsorbante thermofusible et leurs méthodes d'utilisation et de fabrication
US8329292B2 (en) 2006-08-24 2012-12-11 H.B. Fuller Company Absorbent article for absorbing moisture on a structure
CN101517028B (zh) 2006-09-27 2013-07-17 H.B.富勒公司 包含植物蜡的热熔融压敏粘合剂组合物以及包含其的制品
WO2009155115A2 (fr) 2008-05-30 2009-12-23 Reactive Surfaces, Ltd. Revêtements et traitements de surface ayant des enzymes et des peptides actifs
WO2010069334A1 (fr) * 2008-12-19 2010-06-24 Coloplast A/S Pâte adhésive molle pouvant être façonnée
DE102010002622A1 (de) 2010-03-05 2011-09-08 Henkel Ag & Co. Kgaa Ionische Gruppen aufweisender Schmelzklebstoff
DE102010028870A1 (de) 2010-05-11 2011-11-17 Henkel Ag & Co. Kgaa Filmbildender strahlenvernetzender Klebstoff
CN106139225A (zh) * 2010-06-18 2016-11-23 科洛普拉斯特公司 可渗透的压敏粘合剂
US9422463B2 (en) 2012-02-29 2016-08-23 Hollister, Inc. Buffered adhesive compositions for skin-adhering medical products
MX2015012482A (es) * 2013-03-14 2016-04-21 3M Innovative Properties Co Apositos hidrocoloides para heridas con velocidad de trasnmision de vapor de agua (trva) incrementada.
CN108135860A (zh) * 2015-06-22 2018-06-08 考里安国际公司 包含难溶性治疗剂的透皮粘合剂组合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
CN107921175B (zh) 2021-05-28
EP3636290B1 (fr) 2023-07-12
BR112018003328B1 (pt) 2021-09-14
US20180243466A1 (en) 2018-08-30
EP3636290A1 (fr) 2020-04-15
BR112018003328A2 (pt) 2018-09-18
RU2018109087A (ru) 2019-09-26
RU2723557C2 (ru) 2020-06-16
EP3341037A1 (fr) 2018-07-04
US10744224B2 (en) 2020-08-18
CN107921175A (zh) 2018-04-17
WO2017032381A1 (fr) 2017-03-02
US20200338230A1 (en) 2020-10-29
RU2018109087A3 (fr) 2020-01-29

Similar Documents

Publication Publication Date Title
EP3341037B1 (fr) Composition adhésive
US6558792B1 (en) Pressure sensitive adhesive composition
US8809417B2 (en) Soft shapeable adhesive paste
EP2379662B1 (fr) Adhésif autocollant perméable
EP2582405B1 (fr) Adhésif sensible à la pression perméable
US20100204632A1 (en) Permeable pressure sensitive adhesive
CA2718759A1 (fr) Dispositif collecteur de fluides corporels
RU2575586C2 (ru) Проницаемый чувствительный к давлению адгезив

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180326

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIN1 Information on inventor provided before grant (corrected)

Inventor name: KLEIN, CHARLOTTE

Inventor name: ISRAELSON, DORRIT DIANA

Inventor name: OLSEN, HENRIK

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20190503

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1195455

Country of ref document: AT

Kind code of ref document: T

Effective date: 20191115

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602016023371

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200302

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200131

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200130

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200130

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20191030

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200229

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602016023371

Country of ref document: DE

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1195455

Country of ref document: AT

Kind code of ref document: T

Effective date: 20191030

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20200731

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200831

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200831

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200824

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200831

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200824

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191030

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230524

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20230828

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230825

Year of fee payment: 8

Ref country code: DE

Payment date: 20230829

Year of fee payment: 8